Chemotherapy often leaves patients with painful tingling in their hands and feet. This condition is called chemotherapy-induced peripheral neuropathy. It can make daily tasks like buttoning a shirt or holding a cup very difficult. A recent trial looked at whether the drug memantine could help. Seventy-six individuals with this condition took memantine while others took a placebo. The study lasted eight weeks. Both groups felt better, but those taking memantine showed significant improvement in nerve function and pain levels compared to the placebo group. The difference was very strong with a p-value less than 0.001. No serious side effects were reported during the trial. The researchers did not find any safety issues or reasons to stop the medication early. This study offers hope for people struggling with these lingering effects of cancer treatment. However, the results apply only to this specific group and timeframe. More research is needed to confirm these findings for everyone.
Memantine eased nerve pain and tingling for chemotherapy patients in eight weeks
Photo by CDC / Unsplash
What this means for you:
Memantine significantly improved nerve pain and function in chemotherapy patients over eight weeks. More on chemotherapy-induced peripheral neuropathy
Memantine reduced PAC burden and new-onset AF in a Phase 2 randomized trial of 241 adults. Common Heart Flutters May Be Linked to Brain Drug
· Apr 22, 2026
Memantine reduces opioid use but not pain in knee osteoarthritis patients after surgery This Common Memory Drug Cuts Opioid Use After Knee Replacement
· Apr 14, 2026
Chiglitazar reduces liver fat in MASLD patients with hypertriglyceridemia and insulin resistance Two doses of chiglitazar cut liver fat far more than a placebo in 18 weeks
· May 1, 2026
Oral Sodium Butyrate Reduces Weight in Overweight Adults Without Diabetes Oral sodium butyrate helps overweight adults without diabetes lose weight
· May 1, 2026